NEW YORK, Oct. 8 - Celera Genomics' online database business will become profitable by the end of June 2002, Chief Business Officer Peter Barrett told an investor conference here on Monday.

He added that Celera’s acquisition of Axys Pharmaceuticals, announced in June 2001, is expected to close during the current quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.